September 2, 2008 - First Canadian Hospital Installs AutoPulse

INVESTOR CONTACT:

A. Ernest Whiton



Chief Financial Officer



ZOLL Medical Corporation



+1 (978) 421-9655


 
 



PRESS CONTACT:

Diane Egan

Kim Angelastro

ZOLL Medical Corporation

Publicis Consultants | PR
 

+1 (978) 421-9637

+1 (212) 527-8866

degan@zoll.com

kim.angelastro@publicis-pr.com
 

 

 

HOTEL-DIEU GRACE FIRST HOSPITAL IN CANADA TO ADOPT AUTOPULSE

September 2, 2008Chelmsford, MASS.—ZOLL Medical Corporation (Nasdaq GS: ZOLL), a manufacturer of resuscitation devices and related software solutions, announced today that Hotel-Dieu Grace Hospital (HDGH) in Windsor, Ontario is the first hospital in Canada to have installed the Company’s AutoPulse®  Non-Invasive Cardiac Support Pump.  The major cardiac and trauma center, which was also the first hospital in Canada to place AEDs in nursing units, has two AutoPulse units available in the facility’s Critical Care Unit and Emergency Room, and a third device as a back-up.

AutoPulse helps provide the consistent chest compressions called for by the 2005 American Heart Association Guidelines followed by Canada. It is an automated, portable device with an easy-to-use, load-distributing LifeBand® that squeezes the entire chest in an uninterrupted “hands-free” manner, improving blood flow to the heart and brain during cardiac arrest. Additionally, it offers the benefit of freeing up rescuers to focus on other life-saving interventions.

Within the first week of the device being installed, the AutoPulse was being used independently by HDGH staff that had been trained, according to Marg Balzer, Professional Practice Leader at HGDH. The nursing staff immediately supported AutoPulse use in a Code Blue situation due to its ability to provide high-quality compressions.

"Our critical care areas have experienced code situations where the AutoPulse has been used more than once on the same patient.  It is very portable, making it easily accessible for use on a patient that you are concerned about,” Balzer said.  “AutoPulse ensures that we are providing consistent compressions that are hard and fast with good recoil.  It takes away any variances in rescuer technique."

"Utilization of the AutoPulse supports our continued commitment to our community by allowing us to blend cutting edge technology with compassionate care," said Joe O'Beid, Biomedical Technologist.

"We’re extremely pleased that Hotel-Dieu Grace Hospital has adopted this new technology to improve patient care and has so quickly realized clinical improvements,” said Richard A. Packer, Chairman and Chief Executive Officer of ZOLL.

Health Canada, the equivalent to the U.S. Food and Drug Administration, approved the AutoPulse for use in Canada in November 2003.  Currently, it is in use by several EMS agencies in the country. To date, approximately 4,000 AutoPulse units have been deployed in hospitals and emergency services worldwide.

HDGH also uses ZOLL AED Plus® throughout the organization, and has 15 ZOLL R Series® and eight M Series® CCT defibrillators placed in the hospital’s critical care areas.

About Sudden Cardiac Arrest

SCA claims more than 1 million lives each year worldwide. It is the leading cause of unexpected death in the world and strikes without warning. Currently, only about 5 percent of victims survive; 95 percent will die from SCA. SCA is an abrupt disruption of the heart’s function, which causes a lack of blood flow to vital organs.

About Hotel-Dieu Grace Hospital

Hôtel-Dieu Grace Hospital, located in Canada’s southernmost city and just across the river from Detroit, Michigan, is the region’s premier tertiary acute care hospital. HDGH operates 278 patient beds and cares for over 11,000 in-patients annually. Combining a century-old tradition of compassionate care with cutting-edge diagnostic imaging technology, HDGH leads the provision of advanced care in the areas of complex trauma, neurosurgical and stroke care, renal dialysis, acute mental health, cardiac services and the broad foundation of medical and surgical services required to support these areas of specialization.

HDGH has earned a reputation as a leading academic healthcare centre with state-of-the-art technology and a dedicated staff committed to providing exemplary care to patients in our region.

About ZOLL Medical Corporation

ZOLL Medical Corporation is committed to developing technologies that help advance the practice of resuscitation. With products for pacing, defibrillation, circulation, ventilation, and fluid resuscitation, ZOLL provides a comprehensive set of technologies, including Real CPR Help and See-Thru CPR®, that help clinicians, EMS professionals, and lay rescuers resuscitate sudden cardiac arrest or trauma victims. ZOLL also designs and markets software that automates the documentation and management of both clinical and non-clinical information.

ZOLL markets and sells its products in more than 140 countries. The Company has direct operations, distributor networks, and business partners throughout the U.S., Canada, Latin America, Europe, the Middle East and Africa, Asia, and Australia. 2008 marks the 25th anniversary of ZOLL’s resuscitation product development. For more information, visit www.zoll.com.

Certain statements contained in this press release, including statements regarding the future business of the Company, and other statements contained herein regarding matters that are not historical facts, are “forward-looking” statements (as defined in the Private Securities Litigation Reform Act of 1995). Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, those factors discussed in the section entitled “Risk Factors” in the Company's Quarterly Report on Form 10-Q filed with the SEC on August 8, 2008. You should not place undue reliance on the forward-looking statements in this press release, and the Company disavows any obligation to update or supplement those statements in the event of any changes in the facts, circumstances, or expectations that underlie those statements.

Copyright © 2008 ZOLL Medical Corporation. All rights reserved. 269 Mill Road, Chelmsford, MA 01824-4105. ZOLL, AED Plus, AutoPulse, LifeBand, M Series, R Series, Real CPR Help, and See-Thru CPR are registered trademarks of ZOLL Medical Corporation. All product names are the property of their respective owners.